Department of Microbiology, Immunobiology and Genetics, Center of Molecular Biology, Max F. Perutz Laboratories, University of Vienna, Doktor-Bohr-Gasse 9, 1030 Vienna, Austria.
Department of Microbiology, Immunobiology and Genetics, Center of Molecular Biology, Max F. Perutz Laboratories, University of Vienna, Doktor-Bohr-Gasse 9, 1030 Vienna, Austria.
FEBS Lett. 2014 Aug 1;588(15):2398-406. doi: 10.1016/j.febslet.2014.06.025. Epub 2014 Jun 14.
The Raf/Mek/Erk signaling pathway, activated downstream of Ras primarily to promote proliferation, represents the best studied of the evolutionary conserved MAPK cascades. The investigation of the pathway has continued unabated since its discovery roughly 30 years ago. In the last decade, however, the identification of unexpected in vivo functions of pathway components, as well as the discovery of Raf mutations in human cancer, the ensuing quest for inhibitors, and the efforts to understand their mechanism of action, have boosted interest tremendously. From this large body of work, protein-protein interaction has emerged as a recurrent, crucial theme. This review focuses on the role of protein complexes in the regulation of the Raf/Mek/Erk pathway and in its cross-talk with other signaling cascades. Mapping these interactions and finding a way of exploiting them for therapeutic purposes is one of the challenges of future molecule-targeted therapy.
Raf/Mek/Erk 信号通路是 Ras 下游激活的、主要促进增殖的信号通路,是进化上保守的 MAPK 级联反应中研究得最透彻的通路之一。自大约 30 年前发现该通路以来,对其的研究一直在持续进行。然而,在过去十年中,通路组成部分的意想不到的体内功能的鉴定,以及人类癌症中 Raf 突变的发现、对抑制剂的探索,以及对其作用机制的理解,极大地激发了人们的兴趣。从大量的研究中,蛋白质-蛋白质相互作用已经成为一个反复出现的关键主题。这篇综述聚焦于蛋白质复合物在 Raf/Mek/Erk 通路调控以及与其他信号通路交叉对话中的作用。映射这些相互作用并找到利用它们进行治疗的方法是未来分子靶向治疗的挑战之一。